Cargando…
Biomarker discovery and beyond for diagnosis of bladder diseases
Molecular biosignatures of altered cellular landscapes and functions have been casually linked with pathological conditions, which imply the promise of biomarkers specific to bladder diseases, such as bladder cancer and other dysfunctions. Urinary biomarkers are particularly attractive due to costs,...
Autores principales: | Jung, Sungyong, Kim, Jayoung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bladder
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7401981/ https://www.ncbi.nlm.nih.gov/pubmed/32775482 http://dx.doi.org/10.14440/bladder.2020.813 |
Ejemplares similares
-
Application of Low-Cost, Easy-to-Use, Portable Biosensor Systems for Diagnosing Bladder Dysfunctions
por: Myung, Nosang V., et al.
Publicado: (2019) -
'Omics' Approaches to Understanding Interstitial Cystitis/Painful Bladder Syndrome/Bladder Pain Syndrome
por: You, Sungyong, et al.
Publicado: (2012) -
Beyond Gene Discovery in Inflammatory Bowel Disease: The Emerging Role of Epigenetics
por: Ventham, Nicholas T., et al.
Publicado: (2013) -
Moving beyond disclosure: Stages of care in preclinical Alzheimer's disease biomarker testing
por: Ketchum, Fred B., et al.
Publicado: (2022) -
Multiplatform Biomarker Discovery for Bladder Cancer Recurrence Diagnosis
por: De Paoli, Marine, et al.
Publicado: (2016)